Is Astal Laboratories a good stock to invest in?

Astal Laboratories can be analyzed on the following key metrics - TTM P/E: 8.37 Sector P/E: 17.9 Dividend Yield: 0% D/E ratio: -

Astal Laboratories Share Price

Sector: Consumer Financial Services

Powered by

82.10 +1.12 (1.38%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 79.00

Today’s High 82.50

52 Week Low 45.06

52 Week High 131.70

Key Metrics

Market Cap (In Cr) 82.3
Beta -0.28
Div. Yield (%) 0
P/B 2.21
TTM P/E 8.37
Peg Ratio -
Sector P/E 17.9
D/E 0
Open Price 79
Prev Close 80.98

View All Metrics

Astal Laboratories Analysis

Price Analysis

1 Week

1.09%
3 Months

5.17%
6 Month

-3.82%
YTD

-0.02%
1 Year

63.04%

Risk Meter

51% Low risk
51% Moderate risk
51% Balanced Risk
51% High risk
51% Extreme risk

Astal Laboratories Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
64.23

Selling/ General/ Admin Expenses Total
1.34

Depreciation/ Amortization
0.22

Other Operating Expenses Total
2

Total Operating Expense
51.68

Operating Income
12.55

Net Income Before Taxes
11.98

Net Income
8.93

Diluted Normalized EPS
8.04

Period
2024

Total Revenue
23.65

Selling/ General/ Admin Expenses Total
0.47

Depreciation/ Amortization
0.03

Other Operating Expenses Total
0.73

Total Operating Expense
22.56

Operating Income
1.09

Net Income Before Taxes
1.09

Net Income
0.78

Diluted Normalized EPS
0.8

Period
2023

Total Revenue
3.43

Selling/ General/ Admin Expenses Total
0.06

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.15

Total Operating Expense
3.57

Operating Income
-0.15

Net Income Before Taxes
0.03

Net Income
0.02

Diluted Normalized EPS
0.04

Period
2022

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.08

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.12

Total Operating Expense
0.22

Operating Income
-0.22

Net Income Before Taxes
-0.02

Net Income
-0.02

Diluted Normalized EPS
-0.03

Period
2021

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.06

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.12

Total Operating Expense
0.19

Operating Income
-0.19

Net Income Before Taxes
0.01

Net Income
0.01

Diluted Normalized EPS
0.02

Period
2020

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0.02

Other Operating Expenses Total
0.12

Total Operating Expense
0.23

Operating Income
-0.23

Net Income Before Taxes
-0.03

Net Income
-0.03

Diluted Normalized EPS
-0.07

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Astal Laboratories Technical

Moving Average SMA

5 Day79.46
10 Day81.69
20 Day82.8

50 Day83.56
100 Day83.62
300 Day89.48

Astal Laboratories Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Key Corp
130
-4.5
-3.35
354.5
120.5
78

Comfort Fincap
9.12
0.39
4.47
14.15
7
72.89

Astal Laboratories
82.1
1.12
1.38
131.7
45.06
82.3

Srestha Finvest
0.46
-0.01
-2.13
1.28
0.42
75.44

Ncl Research And Financial Ser
0.67
-0.01
-1.47
1.43
0.58
71.71

Astal Laboratories Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

19-May-25
Audited Results

27-Jan-25
Quarterly Results

27-Nov-24
Others

12-Nov-24
Quarterly Results

27-Jul-24
Quarterly Results

06-Jul-24
To consider issue of Warrants & A.G.M.

29-Jun-24
A.G.M. & Issue of Warrants

24-May-24
Audited Results

09-Feb-24
Quarterly Results

20-Dec-23
Preferential issue of shares

Meeting Date
Announced on
Purpose

23-Dec-24
21-Nov-24
POM

05-Aug-24
08-Jul-24
AGM

29-Jan-24
27-Dec-23
POM

18-Sept-23
21-Aug-23
AGM

View All

Company Profile

ABOUT Astal Laboratories

Industry Consumer Financial Services
ISIN INE307N01014
BSE Code 512600

Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.

MANAGEMENT

Balayogiswara Peddinti Chief Financial Officer
Mahendra Kumar Compliance Officer, Company Secretary
Sudheer Kankanala Whole Time Director

ASTAL LABORATORIES SUMMARY

Astal Laboratories is trading 1.38% upper at Rs 82.10 as compared to its last closing price. Astal Laboratories has been trading in the price range of 82.50 & 79.00. Astal Laboratories has given -0.02% in this year & 1.09% in the last 5 days.

Astal Laboratories has TTM P/E ratio 8.37 as compared to the sector P/E of 17.9.

The company posted a net profit of 2.74 Crores in its last quarter.

Listed peers of Astal Laboratories include Key Corp (-3.35%), Comfort Fincap (4.47%), Astal Laboratories (1.38%) etc.

Astal Laboratories has a 19.93% promoter holding & 80.07% public holding.

FAQs about Astal Laboratories

Astal Laboratories is trading at 82.10 as on 27 Jun, 2025 3:27:03 PM. This is 1.38% upper as compared to its previous closing price of 80.98

The market capitalization of Astal Laboratories is 82.3 Cr as on 27 Jun, 2025 3:27:03 PM.

The 52 wk high for Astal Laboratories is 131.70 whereas the 52 wk low is 45.06

Astal Laboratories can be analyzed on the following key metrics -

TTM P/E: 8.37
Sector P/E: 17.9
Dividend Yield: 0%
D/E ratio: -

Astal Laboratories reported a net profit of 8.93 Cr in 2025.

Astal Laboratories Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Astal Laboratories Share Price

Price Range

Key Metrics

Astal Laboratories Analysis

Astal Laboratories Financials

Forecast

Forecast

Forecast

Astal Laboratories Technical

Astal Laboratories Peers

Astal Laboratories Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Astal Laboratories

MANAGEMENT

ASTAL LABORATORIES SUMMARY

FAQs about Astal Laboratories

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue